体外膜氧合幸存者主要不良肾脏事件的决定因素
该单中心回顾性队列纳入2008至2017年Barnes Jewish医院188例体外膜氧合超过24小时且存活出院的成人患者,63%发生急性肾损伤(KDIGO 2-3期),41%需肾脏替代治疗,平均随访3.4年。多因素分析显示急性肾损伤(调整HR=1.79,95%CI 1.00-3.21)、无/部分恢复(调整HR=2.94,95%CI 1.46-5.92)及体外膜氧合当天或之后启动肾脏替代治疗(调整HR=5.4,95%CI 1.14-25.6)是主要不良肾脏事件的显著决定因素。提示出院后需关注肾功能恢复状态及肾脏替代治疗启动时机。
要点
- 188例体外膜氧合存活出院患者中63%发生急性肾损伤(KDIGO 2-3期),41%需肾脏替代治疗,平均随访3.4年。
- 无/部分恢复的急性肾损伤患者主要不良肾脏事件率高于无急性肾损伤者(Kaplan-Meier曲线)。
- 多因素分析:急性肾损伤调整HR=1.79(95%CI 1.00-3.21),无/部分恢复调整HR=2.94(95%CI 1.46-5.92)。
- 体外膜氧合当天或之后启动肾脏替代治疗调整HR=5.4(95%CI 1.14-25.6),为主要不良肾脏事件的显著决定因素。
适用人群与场景
- 2008至2017年Barnes Jewish医院收治、接受体外膜氧合超过24小时且存活至出院的18岁及以上成人患者。
诊断标准与关键阈值
- 主要不良肾脏事件定义:血清肌酐翻倍、新发终末期肾病或死亡。
- 急性肾损伤定义:肾脏疾病:改善全球预后(KDIGO)2-3期。
- 急性肾损伤完全恢复定义:血清肌酐恢复至基线值的50%;部分恢复定义:急性肾损伤分期改善但血清肌酐未恢复至基线值的50%。
研究设计与关键结果
- 研究类型:单中心回顾性队列研究;纳入188例体外膜氧合存活出院患者,63%发生急性肾损伤,41%需肾脏替代治疗,平均随访3.4年。
- Kaplan-Meier生存曲线显示,无/部分恢复的急性肾损伤患者主要不良肾脏事件率高于无急性肾损伤者。
- 多因素分析:急性肾损伤调整HR=1.79(95%CI 1.00-3.21);无/部分恢复调整HR=2.94(95%CI 1.46-5.92);体外膜氧合当天或之后启动肾脏替代治疗调整HR=5.4(95%CI 1.14-25.6),均为主要不良肾脏事件的显著决定因素。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为急性肾损伤、急性肾损伤恢复状态及肾脏替代治疗启动时机是体外膜氧合患者主要不良肾脏事件的决定因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: The majority of extracorporeal membrane oxygenation patients develop acute kidney injury, and 40-60% require renal replacement therapy. This study aimed to examine determinants of major adverse kidney events in extracorporeal membrane oxygenation survivors.
DESIGN: Retrospective cohort study.
SETTING: Barnes Jewish Hospital, St. Louis, MO.
PATIENTS: Patients admitted at Barnes Jewish hospital between 2008 and 2017 and requiring extracorporeal membrane oxygenation. Patients 18 years old and older who survived to hospital discharge were considered for the study.
INTERVENTIONS: None.
MEASURES AND MAIN RESULTS: Patients who were admitted to a single center between 2008 and 2017, were on extracorporeal membrane oxygenation for more than 24 hours and survived hospital discharge were included. Major adverse kidney event was defined as either doubling serum creatinine, incident end-stage renal disease, or death. Acute kidney injury was defined as Kidney Disease: Improving Global Outcomes stages 2-3. Complete acute kidney injury recovery was defined as a return to 50% of baseline serum creatinine and partial recovery as an improvement in acute kidney injury stage without a return to 50% of baseline serum creatinine. Survival analysis plots and Cox regression models were fitted to examine the associations of acute kidney injury status, acute kidney injury recovery, and other factors with major adverse kidney event. Among 188 extracorporeal membrane oxygenation patients who survived until hospital discharge, 63% had acute kidney injury and 41% required renal replacement therapy. The mean follow-up time was 3.4 years. Kaplan-Meier survival curves showed that patients with no/partial recovery from acute kidney injury had a higher rate of major adverse kidney event compared with those with no acute kidney injury. Multivariate analysis showed that acute kidney injury (adjusted hazard ratio =1.79 [95% CI = 1.00-3.21]), no/partial recovery from acute kidney injury (adjusted hazard ratio = 2.94 [95% CI = 1.46-5.92]), and initiation of renal replacement therapy on the day or after extracorporeal membrane oxygenation (adjusted hazard ratio = 5.4 [95% CI = 1.14-25.6]) were significant determinants of major adverse kidney event after adjustment for potential confounders.
CONCLUSIONS: Acute kidney injury, acute kidney injury recovery status, and timing of initiation of renal replacement therapy are determinants of major adverse kidney events in patients who received extracorporeal membrane oxygenation.
参考来源
- Bobba A, Costanian C, Bahous SA, et al. Determinants of Major Adverse Kidney Events in Extracorporeal Membrane Oxygenation Survivors. Crit Care Explor. 2022. PMID: 35187498. doi:10.1097/CCE.0000000000000636
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。